If you are one of the nearly 1.3 million Americans living with Inflammatory bowel disease, or IBD, you probably know how costly and challenging it can be. Jeffrey Berinstein, M.D., a gastroenterologist and clinical instructor at Michigan Medicine, shares how he and a team of experts were inspired to examine if a more coordinated approach to health care could eventually alleviate the cost and symptom burdens associated with IBD. Berinstein shares insights from his research and hopes for a better, more cost-effective approach to caring for high-risk patients with IBD.
Free Cooler. Join for Life.